COVID-19: Reasons for Guarded Optimism

被引：0
作者：
Snell, Noel [1 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
来源：
PHARMACEUTICAL MEDICINE | 2021年 / 35卷 / 02期
关键词：
D O I：
10.1007/s40290-021-00381-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：67 / 69
页数：3
相关论文
共 29 条
  • [1] Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
    Agarwal, Anup
    Mukherjee, Aparna
    Kumar, Gunjan
    Chatterjee, Pranab
    Bhatnagar, Tarun
    Malhotra, Pankaj
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [2] Arnold C, 2020, NEW SCI, V245, P36
  • [3] Covid-19-The Search for Effective Therapy
    Baden, Lindsey R.
    Rubin, Eric J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19) : 1851 - 1852
  • [4] Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
    Cinatl, J
    Morgenstern, B
    Bauer, G
    Chandra, P
    Rabenau, H
    Doerr, HW
    [J]. LANCET, 2003, 361 (9374) : 2045 - 2046
  • [5] Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment
    Davies, Miranda
    Osborne, Vicki
    Lane, Samantha
    Roy, Debabrata
    Dhanda, Sandeep
    Evans, Alison
    Shakir, Saad
    [J]. DRUG SAFETY, 2020, 43 (07) : 645 - 656
  • [6] de Vrieze J, 2021, SCIENCE, V371, P10, DOI 10.1126/science.371.6524.10
  • [7] Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386
  • [8] HIGGINS P G, 1991, Antiviral Chemistry and Chemotherapy, V2, P61
  • [9] Vitamin C-An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19
    Holford, Patrick
    Carr, Anitra C.
    Jovic, Thomas H.
    Ali, Stephen R.
    Whitaker, Iain S.
    Marik, Paul E.
    Smith, A. David
    [J]. NUTRIENTS, 2020, 12 (12) : 1 - 17
  • [10] Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
123